Brind.

Investigative Reporting Leads to Fraud Fines for Bristol-Myers Squibb and Book on Johnson…

1 report, 1 independent Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Gardiner Harris's investigative reporting helped lead to fraud fines against Bristol-Myers Squibb. Harris subsequently authored a book dissecting nine scandals involving Johnson & Johnson, including the presence of asbestos in its talcum powder and the withdrawal of its Covid-19 vaccine.

From elpais.com

Why it matters

Some supportBrind's analysis of the reports

The reporting highlights issues of corporate behavior and regulatory oversight within the pharmaceutical industry. Harris's earlier work also contributed to the passage of the Sunshine Act, which mandates that drug companies disclose payments made to doctors.

From elpais.com

Who's involved

  • Bristol-Myers SquibbSubject of fraud fines resulting from Gardiner Harris's reporting.
  • Johnson & JohnsonSubject of a book dissecting nine scandals, including talcum powder and vaccine issues.
  • Gardiner HarrisJournalist whose reporting led to fraud fines and who authored the book.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Bristol-Myers SquibbSpeculative

    The company might face increased operational costs due to regulatory fines.

  • Johnson & JohnsonSpeculative

    Competitors of Johnson & Johnson might see changes in market demand due to public scrutiny over past scandals.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped